Kiluma Biosciences

Partnerships

Partnering to transform the future of cancer detection.

Kiluma Biosciences partners with pharmaceutical companies, academic institutions, healthcare systems, laboratories, and biotechnology innovators to accelerate the development, validation, and commercialization of next-generation oncology diagnostics.

Explore Partnership Opportunities Schedule a Scientific Discussion

A Global Collaboration Network

Building a Global Precision Oncology
Partnership Network.

Kiluma Biosciences collaborates with academic institutions, cancer centers, pharmaceutical companies, diagnostic laboratories, biobanks, and healthcare organizations to accelerate the development of next-generation molecular diagnostics.

ResearchClinicalCommercialTechnology

Core Platform

InterceptIQ™

Precision oncology platform

  1. Research

    Academic Medical Centers

    Translational research, investigator-initiated studies, and co-authored discovery science.

    Collaboration opportunities

    • Investigator-initiated studies
    • Translational research
    • Biomarker discovery
    • Clinical publications
    • Multi-center collaborations
  2. Research

    Cancer Research Institutes

    Discovery science, dedicated oncology programs, and longitudinal cohort research.

    Collaboration opportunities

    • Discovery science programs
    • Longitudinal cohort studies
    • Tumor biology research
    • Translational pilot studies
  3. Clinical

    Comprehensive Cancer Centers

    Prospective studies, high-risk surveillance cohorts, and clinical workflow integration.

    Collaboration opportunities

    • High-risk surveillance cohorts
    • Prospective validation studies
    • Clinical workflow integration
    • Standard-of-care comparison
  4. Commercial

    Pharmaceutical Companies

    Companion diagnostics, drug development support, and clinical trial stratification.

    Collaboration opportunities

    • Companion diagnostics
    • Drug development support
    • Clinical trial stratification
    • Therapeutic monitoring
    • Biomarker partnerships
  5. Commercial

    Diagnostic Laboratories

    Reference lab implementation, assay validation, and multi-site deployment.

    Collaboration opportunities

    • Reference lab implementation
    • LDT development & validation
    • Multi-site assay deployment
    • Quality control frameworks
  6. Research

    Biobanks

    Retrospective plasma and tissue studies on annotated archived specimens.

    Collaboration opportunities

    • Retrospective sample studies
    • Analytical validation
    • Biomarker verification
    • Multi-omic discovery
  7. Technology

    AI & Bioinformatics Partners

    Multi-omic modeling, predictive analytics, and clinical decision support.

    Collaboration opportunities

    • Multi-omic data modeling
    • Predictive algorithm development
    • Clinical decision support
    • Real-world evidence analytics
  8. Clinical

    Healthcare Systems

    Earlier-detection pathways, high-risk referral programs, and population health.

    Collaboration opportunities

    • Population screening programs
    • High-risk referral pathways
    • Early detection clinics
    • Community health initiatives
  9. Research

    Translational Research Organizations

    Bench-to-bedside study execution, central lab services, and translational analytics.

    Collaboration opportunities

    • Central lab biomarker testing
    • Translational study design
    • Endpoint analysis
    • Regulatory science support
  10. Research

    International Research Collaborators

    Global consortia, cross-border cohorts, and international research partnerships.

    Collaboration opportunities

    • Global research consortia
    • Cross-border cohort studies
    • International biobank access
    • Multi-national publications

How We Work Together

From scientific discussion to clinical translation.

A structured, transparent path that respects scientific rigor at every stage.

  1. 01

    Scientific Discussion

    An initial conversation with our scientific team to align on shared interests.

  2. 02

    Opportunity Assessment

    Joint evaluation of scientific fit, feasibility, and potential collaboration models.

  3. 03

    Study Design

    Co-developed protocols, endpoints, and analytical plans grounded in clinical relevance.

  4. 04

    Research Collaboration

    Active execution — specimens, sequencing, biomarker analysis, and data sharing.

  5. 05

    Clinical Validation

    Rigorous validation across cohorts to support analytical and clinical performance.

  6. 06

    Publication

    Co-authored peer-reviewed publications and scientific presentations.

  7. 07

    Commercial Translation

    Pathways toward clinical implementation, regulatory readiness, and broader access.

Diverse scientists and physicians collaborating around molecular data displays in a modern academic medical center.

Academic & Clinical Research

Bridging discovery and clinical impact through collaborative science.

Partnership Opportunities

Ways to collaborate

Whether you're advancing discovery science, validating new diagnostics, or scaling clinical implementation — there's a structured path to work with Kiluma.

Academic Research Partnerships

Advance biomarker discovery and translational oncology research.

  • Investigator-initiated studies
  • Biomarker discovery
  • Multi-omic research
  • Tissue and plasma correlation studies
  • Translational research programs
  • Publication collaborations
  • Grant-supported research
  • Student and fellowship programs

Ideal partners: Universities · Academic medical centers · Cancer institutes · Research hospitals

Clinical Validation Studies

Support validation of novel liquid biopsy technologies.

  • Prospective clinical studies
  • Retrospective sample analysis
  • Multi-site validation
  • Longitudinal disease progression studies
  • Diagnostic performance studies
  • Standard-of-care comparison
  • High-risk surveillance cohorts

Pilot Studies

Launch New Diagnostic Research Programs

Rapidly establish pilots evaluating emerging biomarkers and liquid biopsy technologies.

  • High-risk pancreatic surveillance
  • Incidental imaging follow-up
  • New-onset diabetes cohorts
  • Hereditary cancer programs
  • Early detection feasibility studies
  • Community health screening
DesignIRBEnrollmentAssayAnalysisPublication

Biobank Collaborations

Unlock the Value of Existing Biospecimens

Evaluate novel molecular biomarkers using archived specimens.

  • Retrospective plasma analysis
  • Serum repositories
  • Tissue-linked liquid biopsy studies
  • Longitudinal cohorts
  • Multi-omic discovery
  • Biomarker validation
Biobank specimensMolecular profilingBiomarker discoveryClinical validation

Pharmaceutical Partnerships

Companion Diagnostics & Therapeutic Innovation

Integrate diagnostics across the therapeutic development lifecycle.

  • Companion diagnostics
  • Patient stratification
  • Clinical trial enrichment
  • Pharmacodynamic biomarkers
  • Treatment response monitoring
  • Disease progression monitoring
  • Precision medicine programs
  • Drug development support
  • Clinical trial endpoints
DiscoveryPreclinicalPhase I–IIIApprovalCommercialization

Diagnostic & Laboratory Partnerships

Expand Precision Diagnostics Together

  • Reference laboratory implementation
  • Laboratory-developed tests
  • Technology licensing
  • Clinical laboratory validation
  • Multi-site deployment
  • Workflow integration
  • International laboratory expansion
  • Strategic commercialization

CRO Partnerships

Accelerating Clinical Research

  • Biomarker testing
  • Central laboratory services
  • Clinical trial support
  • Molecular analytics
  • Sample logistics
  • Endpoint analysis

AI & Bioinformatics Partnerships

Building the Future of Precision Oncology

  • Artificial intelligence
  • Machine learning
  • Predictive modeling
  • Multi-omic integration
  • Clinical decision support
  • Molecular data analytics
  • Risk prediction algorithms

Healthcare System Partnerships

Implement Earlier Cancer Detection

  • High-risk surveillance programs
  • Precision screening
  • Integrated diagnostic pathways
  • Community outreach
  • Population health initiatives
  • Early detection clinics
Physicians and clinical teams reviewing diagnostic data in a modern hospital environment.

Healthcare Systems

Implementing earlier detection at the point of care.

How We Work Together

A clear path from idea to impact

Every collaboration follows a structured, transparent process designed to move quickly without compromising scientific rigor.

  1. 01

    Initial Discussion

  2. 02

    Scientific Evaluation

  3. 03

    Opportunity Assessment

  4. 04

    Study Design

  5. 05

    Collaboration Agreement

  6. 06

    Execution

  7. 07

    Data Generation

  8. 08

    Publication / Regulatory Support

  9. 09

    Commercialization

Why Partner With Kiluma

The advantage of working with us

Novel Molecular Diagnostics Platform

Multi-Omic Biomarker Expertise

Liquid Biopsy Innovation

Translational Science

Flexible Collaboration Models

Clinical Research Experience

Academic Partnerships

Commercial Development Expertise

Precision Oncology Focus

Rapid Pilot Study Execution

Partner Types

Find where your organization fits

Click any partner type to see tailored collaboration opportunities.

Scientists working with advanced molecular diagnostics equipment in a cutting-edge laboratory.

Diagnostic Laboratories

Scaling precision diagnostics through reference lab networks.

Next Steps

Let's build the future of cancer detection together

  1. STEP 01

    Scientific Discovery Call

    Align on shared scientific and clinical priorities.

  2. STEP 02

    Technical & Clinical Review

    Evaluate feasibility, fit, and study design options.

  3. STEP 03

    Collaboration Planning

    Define scope, milestones, and partnership model.

  4. STEP 04

    Pilot or Validation Study

    Execute a focused study to generate evidence.

  5. STEP 05

    Long-Term Strategic Partnership

    Scale into multi-year programs and commercialization.

Start a Partnership Discussion